This program focuses on exploring RNA-based clinical applications in cancer therapy. The training will include specialized knowledge of RNA and tumor biology, identification and design of RNA-based biomarkers and therapeutics, as well as critical thinking and empirical research capabilities. Participants that have completed the training may be considered for funding support to study in TMU’s Master’s Program or Ph.D. program of Cancer Biology and Drug Development at Taipei Medical University.